1. Kass MA, Heuer DK, Higginbotham EJ. . The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120:701–13.
2. Miglior S, Zeyen T, Pfeiffer N. . Results of the European Glaucoma Prevention Study. Ophthalmology. 2005; 112:366–75.
3. Gupta N, Krishnadev N, Hamstra SJ, Yücel YH. Depth perception deficits in glaucoma suspects. Br J Ophthalmol. 2006; 90:979–81.
Article
4. Ramulu PY, West SK, Munoz, B. . Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project. Ophthalmology. 2009; 116:1846–53.
5. McGwin G Jr, Xie A, Mays A. . Visual field defects and the risk of motor vehicle collisions among patients with glaucoma. Invest Ophthalmol Vis Sci. 2005; 46:4437–41.
6. Patino CM, McKean-Cowdin R, Azen SP. . Central and periph-eral visual impairment and the risk of falls and falls with injury. Ophthalmology. 2010; 117:199–206.
Article
7. Gutierrez P, Wilson MR, Johnson C. . Influence of glaucoma-tous visual field loss on health-related quality of life. Arch Ophthalmol. 1997; 115:777–84.
Article
8. Janz NK, Wren PA, Lichter PR. . Quality of life in newly diag-nosed glaucoma patients : The Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2001; 108:887–97.
9. McKean-Cowdin R, Wang Y, Wu J. . Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008; 115:941–8.e1.
10. Parrish RK 2nd, Gedde SJ, Scott IU. . Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997; 115:1447–55.
Article
11. van Gestel A, Webers CA, Beckers HJ. . The relationship be-tween visual field loss in glaucoma and health-related qual-ity-of-life. Eye (Lond). 2010; 24:1759–69.
Article
12. Varma R, Wu J, Chong K. . Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology. 2006; 113:1846–53.
Article
13. Friedman DS, Freeman E, Munoz B. . Glaucoma and mobility performance: the Salisbury Eye Evaluation Project. Ophthalmology. 2007; 114:2232–7.
14. Owen VM, Crabb DP, White ET. . Glaucoma and fitness to drive: using binocular visual fields to predict a milestone to blindness. Invest Ophthalmol Vis Sci. 2008; 49:2449–55.
Article
15. Jampel HD, Friedman DS, Quigley H, Miller R. Correlation of the binocular visual field with patient assessment of vision. Invest Ophthalmol Vis Sci. 2002; 43:1059–67.
16. Crabb DP, Viswanathan AC, McNaught AI. . Simulating bin-ocular visual field status in glaucoma. Br J Ophthalmol. 1998; 82:1236–41.
Article
17. Nelson-Quigg JM, Cello K, Johnson CA. Predicting binocular vis-ual field sensitivity from monocular visual field results. Invest Ophthalmol Vis Sci. 2000; 41:2212–21.
18. Crabb DP, Fitzke FW, Hitchings RA, Viswanathan AC. A practical approach to measuring the visual field component of fitness to drive. Br J Ophthalmol. 2004; 88:1191–6.
Article
19. Legge GE. Binocular contrast summation–II. Quadratic summation. Vision Res. 1984; 24:385–94.
20. Anderson DR. The single field printout with Statpac analysis. Kist K, ed. Automated Static Perimetry. St. Louis: MO Mosby;1992; 84.
21. Esterman B. Functional scoring of the binocular field. Ophthalmology. 1982; 89:1226–34.
Article
22. Jampel HD. Glaucoma patients' assessment of their visual function and quality of life. Trans Am Ophthalmol Soc. 2001; 99:301–17.
Article
23. Mills RP. Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis. Trans Am Ophthalmol Soc. 1998; 96:753–812.
24. Campbell FW, Green DG. Monocular versus binocular visual acuity. Nature. 1965; 208:191–2.
Article
25. Meese TS, Georgeson MA, Baker DH. Binocular contrast vision at and above threshold. J Vis. 2006; 6:1224–43.
Article
26. Simpson WA, Manahilov V, Shahani U. Two eyes: square root 2 better than one? Acta Psychol (Amst). 2009; 131:93–8.
27. Asaoka R, Crabb DP, Yamashita T. . Patients have two eyes!: binocular versus better eye visual field indices. Invest Ophthalmol Vis Sci. 2011; 52:7007–11.
Article